These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 33830701)

  • 41. First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing.
    Wolfson AR; Robinson LB; Li L; McMahon AE; Cogan AS; Fu X; Wickner P; Samarakoon U; Saff RR; Blumenthal KG; Banerji A
    J Allergy Clin Immunol Pract; 2021 Sep; 9(9):3308-3320.e3. PubMed ID: 34166844
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Unfolding the Determinants of COVID-19 Vaccine Acceptance in China.
    Yin F; Wu Z; Xia X; Ji M; Wang Y; Hu Z
    J Med Internet Res; 2021 Jan; 23(1):e26089. PubMed ID: 33400682
    [TBL] [Abstract][Full Text] [Related]  

  • 43. COVID-19: Significance of antibodies.
    Assadiasl S; Fatahi Y; Zavvar M; Nicknam MH
    Hum Antibodies; 2020; 28(4):287-297. PubMed ID: 32986664
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations.
    Sultana J; Mazzaglia G; Luxi N; Cancellieri A; Capuano A; Ferrajolo C; de Waure C; Ferlazzo G; Trifirò G
    Expert Rev Vaccines; 2020 Oct; 19(10):919-936. PubMed ID: 32940090
    [No Abstract]   [Full Text] [Related]  

  • 45. Frontrunners in the race to develop a SARS-CoV-2 vaccine.
    Russell RL; Pelka P; Mark BL
    Can J Microbiol; 2021 Mar; 67(3):189-212. PubMed ID: 33264067
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [MANAGEMENT, DIAGNOSIS, AND TREATMENT OF SEVERE ALLERGIC REACTIONS INCLUDING ANAPHYLAXIS TO COVID-19 VACCINE].
    Asano K; Fujisawa T; Nakamura Y; Nagata M; Hide M; Fujieda S
    Arerugi; 2021; 70(3):215-223. PubMed ID: 34011777
    [No Abstract]   [Full Text] [Related]  

  • 47. Countries with similar COVID-19 vaccination rates yet divergent outcomes: are all vaccines created equal?
    Alhinai ZA; Elsidig N
    Int J Infect Dis; 2021 Sep; 110():258-260. PubMed ID: 34157386
    [TBL] [Abstract][Full Text] [Related]  

  • 48. After the Storm: Ophthalmic Manifestations of COVID-19 Vaccines.
    Sen M; Honavar SG
    Indian J Ophthalmol; 2021 Dec; 69(12):3398-3420. PubMed ID: 34826968
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of patients at risk of anaphylaxis after COVID 19 vaccination.
    Gangemi S; Allegra A; Di Gioacchino M
    J Biol Regul Homeost Agents; 2021; 35(3):843-846. PubMed ID: 34231348
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external experts.
    Ring J; Worm M; Wollenberg A; Thyssen JP; Jakob T; Klimek L; Bangert C; Barbarot S; Bieber T; de Bruin-Weller MS; Chernyshov PV; Christen-Zaech S; Cork M; Darsow U; Flohr C; Fölster-Holst R; Gelmetti C; Gieler U; Gutermuth J; Heratizadeh A; Hijnen DJ; von Kobyletzki LB; Kunz B; Paul C; De Raeve L; Seneschal J; Simon D; Spuls PI; Stalder JF; Svensson A; Szalai Z; Taieb A; Torrelo A; Trzeciak M; Vestergaard C; Werfel T; Weidinger S; Deleuran M
    J Eur Acad Dermatol Venereol; 2021 Jun; 35(6):e362-e365. PubMed ID: 33752263
    [No Abstract]   [Full Text] [Related]  

  • 51. A Community Partnered Approach to Promoting COVID-19 Vaccine Equity.
    Scott T; Gutschow B; Ragavan MI; Ho K; Massart M; Ripper L; Muthama V; Miller E; Bey J; Abernathy RP
    Health Promot Pract; 2021 Nov; 22(6):758-760. PubMed ID: 34311592
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and landscape of Covid-19 vaccines: a review article.
    Azevedo TCP; Freitas PV; Cunha PHPD; Moreira EAP; Rocha TJM; Barbosa FT; Sousa-Rodrigues CF; Ramos FWDS
    Rev Assoc Med Bras (1992); 2021 Jan; 67(3):474-478. PubMed ID: 34468617
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine.
    Yacoub MR; Cucca V; Asperti C; Ramirez GA; Della-Torre E; Moro M; Zandalasini C; Di Napoli D; Ambrosio A; Signorelli C; Colombo S; Beretta L; Ciceri F; Zangrillo A; Dagna L
    Vaccine; 2021 Oct; 39(44):6464-6469. PubMed ID: 34598820
    [TBL] [Abstract][Full Text] [Related]  

  • 54. mRNA COVID-19 Vaccine Anaphylaxis: Epidemiology, Risk Factors, and Evaluation.
    Jaggers J; Wolfson AR
    Curr Allergy Asthma Rep; 2023 Mar; 23(3):195-200. PubMed ID: 36689047
    [TBL] [Abstract][Full Text] [Related]  

  • 55. When is it reasonable to extrapolate during a pandemic?: The case of broad UK labeling for AstraZeneca COVID-19 vaccine.
    Dal-Ré R; Banzi R
    Eur J Intern Med; 2021 May; 87():1-2. PubMed ID: 33810939
    [No Abstract]   [Full Text] [Related]  

  • 56. Nano-carriers of COVID-19 vaccines: the main pillars of efficacy.
    Constantin C; Pisani A; Bardi G; Neagu M
    Nanomedicine (Lond); 2021 Nov; 16(26):2377-2387. PubMed ID: 34632802
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PEG skin testing for COVID-19 vaccine allergy.
    Stone BD
    J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1765. PubMed ID: 33838847
    [No Abstract]   [Full Text] [Related]  

  • 58. The Global Interest in Vaccines and Its Prediction and Perspectives in the Era of COVID-19. Real-Time Surveillance Using Google Trends.
    Sycinska-Dziarnowska M; Paradowska-Stankiewicz I; Woźniak K
    Int J Environ Res Public Health; 2021 Jul; 18(15):. PubMed ID: 34360134
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Palms and soles itchiness as a side effect of COVID-19 vaccination.
    Al-Ansari RY; Al-Sharari M; Al-Saadi T
    J Infect Public Health; 2021 Oct; 14(10):1389-1391. PubMed ID: 34391695
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Allergic Reactions to COVID-19 Vaccines: Risk Factors, Frequency, Mechanisms and Management.
    Luxi N; Giovanazzi A; Arcolaci A; Bonadonna P; Crivellaro MA; Cutroneo PM; Ferrajolo C; Furci F; Guidolin L; Moretti U; Olivieri E; Petrelli G; Zanoni G; Senna G; Trifirò G
    BioDrugs; 2022 Jul; 36(4):443-458. PubMed ID: 35696066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.